Frontlight ResearchEarly access
Trial site
Centre de Recherches Médicales de Lambaréné (CERMEL)
- 2closed trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Tuberculosis1 trial
- Phase
- Phase 22 trials
- Status
- Completed2 trials
- Lead sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 trial
- Michael Hoelscher1 trial
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026